146 related articles for article (PubMed ID: 26524640)
1. Serum antinuclear and extractable nuclear antigen antibody prevalence and associated morbidity and mortality in the general population over 15 years.
Selmi C; Ceribelli A; Generali E; Scirè CA; Alborghetti F; Colloredo G; Porrati L; Achenza MI; De Santis M; Cavaciocchi F; Massarotti M; Isailovic N; Paleari V; Invernizzi P; Matthias T; Zucchi A; Meroni PL
Autoimmun Rev; 2016 Feb; 15(2):162-6. PubMed ID: 26524640
[TBL] [Abstract][Full Text] [Related]
2. Utility of age, gender, ANA titer and pattern as predictors of anti-ENA and -dsDNA antibodies.
Kang I; Siperstein R; Quan T; Breitenstein ML
Clin Rheumatol; 2004 Dec; 23(6):509-15. PubMed ID: 15801070
[TBL] [Abstract][Full Text] [Related]
3. Association of Immunofluorescence pattern of Antinuclear Antibody with Specific Autoantibodies in the Bangladeshi Population.
Sharmin S; Ahmed S; Abu Saleh A; Rahman F; Choudhury MR; Hassan MM
Bangladesh Med Res Counc Bull; 2014 Aug; 40(2):74-8. PubMed ID: 26415344
[TBL] [Abstract][Full Text] [Related]
4. [Prevalence and diagnostic value of antinuclear antibodies without identified antigenic target: a retrospective study of 90 patients].
Feki S; Frikha F; Ben Hadj Hmida Y; Abed S; Ben Ayed M; Turki H; Hachicha J; Baklouti S; Bahloul Z; Masmoudi H
Rev Med Interne; 2012 Sep; 33(9):475-81. PubMed ID: 22658165
[TBL] [Abstract][Full Text] [Related]
5. From ANA to ENA: how to proceed?
Damoiseaux JG; Tervaert JW
Autoimmun Rev; 2006 Jan; 5(1):10-7. PubMed ID: 16338206
[TBL] [Abstract][Full Text] [Related]
6. Outcome of positive antinuclear antibodies in individuals without connective tissue disease.
Myckatyn SO; Russell AS
J Rheumatol; 2003 Apr; 30(4):736-9. PubMed ID: 12672192
[TBL] [Abstract][Full Text] [Related]
7. Clinical features of 39 patients with antibodies to extractable nuclear antigens despite negative antinuclear antibodies: evidence for autoimmunity including neurologic and connective tissue diseases.
Davis JM; Moder KG; Homburger HA; Ytterberg SR
Medicine (Baltimore); 2005 Jul; 84(4):208-217. PubMed ID: 16010205
[TBL] [Abstract][Full Text] [Related]
8. The relationship between antinuclear antibody data and antibodies against extractable nuclear antigens in a large laboratory cohort.
Craig WY; Ledue TB
Clin Chem Lab Med; 2011 Nov; 50(3):497-502. PubMed ID: 22098438
[TBL] [Abstract][Full Text] [Related]
9. Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing.
Peene I; Meheus L; Veys EM; De Keyser F
Ann Rheum Dis; 2001 Dec; 60(12):1131-6. PubMed ID: 11709455
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of systemic autoimmune rheumatic diseases and clinical significance of ANA profile: data from a tertiary hospital in Shanghai, China.
Yang Z; Ren Y; Liu D; Lin F; Liang Y
APMIS; 2016 Sep; 124(9):805-11. PubMed ID: 27328803
[TBL] [Abstract][Full Text] [Related]
11. [Detection of anti-SSA/Ro antibody by ELISA, double immunodiffusion, and immunoblotting: a comparative study].
Tong SQ; Shi Q; Wen XH; Gan XD; Shi YP; Zhao Y; Zeng XF; Zhang FC; Dong Y
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2455-7. PubMed ID: 17156670
[TBL] [Abstract][Full Text] [Related]
12. Determination of Specificity and Pattern of Antinuclear Antibodies (ANA) in Systemic Rheumatic Disease Patients Positive for ANA Testing.
Tipu HN; Bashir MM
J Coll Physicians Surg Pak; 2018 Jan; 28(1):40-43. PubMed ID: 29290190
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of indirect immunofluorescence and enzyme immunoassay methods for the determination of antinuclear antibodies].
Yilmaz O; Karaman M; Ergon MC; Bahar IH; Yuluğ N
Mikrobiyol Bul; 2004; 38(1-2):85-90. PubMed ID: 15293906
[TBL] [Abstract][Full Text] [Related]
14. Validation of a new screening strategy for anti-extractable nuclear antigen antibodies.
Van Praet JT; Vander Cruyssen B; Bonroy C; Smith V; Delanghe J; De Keyser F
Clin Exp Rheumatol; 2009; 27(6):971-6. PubMed ID: 20149314
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and clinical significance of elevated antinuclear antibody test in children and adult patients with idiopathic thrombocytopenic purpura.
Altintas A; Ozel A; Okur N; Okur N; Cil T; Pasa S; Ayyildiz O
J Thromb Thrombolysis; 2007 Oct; 24(2):163-8. PubMed ID: 17436144
[TBL] [Abstract][Full Text] [Related]
16. Laboratory screening of connective tissue diseases by a new automated ENA screening assay (EliA Symphony) in clinically defined patients.
González C; García-Berrocal B; Pérez M; Navajo JA; Herraez O; González-Buitrago JM
Clin Chim Acta; 2005 Sep; 359(1-2):109-14. PubMed ID: 15894301
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of determination of DFS70 antibodies to rule out connective tissue diseases].
Kiefer D; von Brunn M; Baraliakos X; Andreica I; Braun J
Z Rheumatol; 2020 Oct; 79(8):749-754. PubMed ID: 31889213
[TBL] [Abstract][Full Text] [Related]
18. Anti-nuclear antibodies in patients with breast cancer.
Nisihara R; Machoski MCC; Neppel A; Maestri CA; Messias-Reason I; Skare TL
Clin Exp Immunol; 2018 Aug; 193(2):178-182. PubMed ID: 29645079
[TBL] [Abstract][Full Text] [Related]
19. Antibodies against antigens related to scleroderma in a cohort of patients with morphea.
Arisi M; Cavazzana I; Cerutti ME; Ferrari F; Carabellese N; Rossi MT; Tincani A; Calzavara-Pinton P; Franceschini F
G Ital Dermatol Venereol; 2018 Aug; 153(4):451-458. PubMed ID: 27706114
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of simultaneous detection of specific antinuclear antibodies using multiplexed technology].
Uto K; Hayashi N; Kinoshita S; Kawano S; Kumagai S
Rinsho Byori; 2009 Oct; 57(10):941-53. PubMed ID: 19928490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
